A Study to Evaluate the Safety, Tolerability of INCB160058 in Participants With Myeloproliferative Neoplasms
Clinical trial NCT06313593 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06313593
- Sponsor
- Incyte Corporation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-08
- Primary completion
- 2028-10-09
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.